Smaldone Alsup Laurie — SEC insider filings

SEC reporting owner CIK 1589602. 37 insider filings on record with FilingPulse; latest filed 2026-09-24.

Transaction summary — filings shown

Covers all 37 filings on record, filed 2020-09-02 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Theravance Biopharma, Inc. (TBPH)Director7——24
BLACKBERRY Ltd (BB)Director17——17
ARVINAS, INC. (ARVN)Director6——10
Kinnate Biopharma Inc. (KNTE)Director4——7
PARDES BIOSCIENCES, INC. (PRDS)Director3——4

Insider filings — Smaldone Alsup Laurie

FiledFormIssuerReported transactionsSource
2026-09-244Theravance Biopharma, Inc. (TBPH)Disposition to issuer (D): 74,980 · Disposition to issuer (D): 6,009 · Disposition to issuer (D): 13,500 (derivative) · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 6,000 (derivative) · +6 moreEDGAR
2026-06-264ARVINAS, INC. (ARVN)Grant/award (A): 15,527 @ $0 · Grant/award (A): 22,714 (derivative) @ $0EDGAR
2026-06-164Theravance Biopharma, Inc. (TBPH)Grant/award (A): 6,009 @ $0 · Grant/award (A): 13,398 (derivative) @ $0EDGAR
2025-06-274ARVINAS, INC. (ARVN)Grant/award (A): 16,025 @ $0 · Grant/award (A): 23,105 (derivative) @ $0EDGAR
2025-05-214Theravance Biopharma, Inc. (TBPH)Grant/award (A): 10,649 @ $0 · Grant/award (A): 24,258 (derivative) @ $0EDGAR
2024-06-264BLACKBERRY Ltd (BB)Grant/award (A): 5,994 (derivative)EDGAR
2024-06-044BLACKBERRY Ltd (BB)Grant/award (A): 17,763 (derivative)EDGAR
2024-05-314ARVINAS, INC. (ARVN)Grant/award (A): 5,899 @ $0 · Grant/award (A): 9,070 (derivative) @ $0EDGAR
2024-05-104Theravance Biopharma, Inc. (TBPH)Grant/award (A): 10,537 @ $0 · Grant/award (A): 23,576 (derivative) @ $0EDGAR
2024-04-054Kinnate Biopharma Inc. (KNTE)Disposition to issuer (D): 60,751 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 25,000 (derivative)EDGAR
2024-03-044BLACKBERRY Ltd (BB)Grant/award (A): 17,763 (derivative)EDGAR
2023-12-044BLACKBERRY Ltd (BB)Grant/award (A): 13,554 (derivative)EDGAR
2023-09-014BLACKBERRY Ltd (BB)Grant/award (A): 8,953 (derivative) @ $0EDGAR
2023-08-314PARDES BIOSCIENCES, INC. (PRDS)Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 75,000 (derivative)EDGAR
2023-06-204ARVINAS, INC. (ARVN)Grant/award (A): 4,121 @ $0 · Grant/award (A): 12,787 (derivative) @ $0EDGAR
2023-06-134Kinnate Biopharma Inc. (KNTE)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-024PARDES BIOSCIENCES, INC. (PRDS)Grant/award (A): 37,500 (derivative) @ $0EDGAR
2023-06-014BLACKBERRY Ltd (BB)Grant/award (A): 9,259 (derivative) @ $0EDGAR
2023-05-044Theravance Biopharma, Inc. (TBPH)Grant/award (A): 9,132 @ $0 · Grant/award (A): 22,044 (derivative) @ $0EDGAR
2023-03-014BLACKBERRY Ltd (BB)Grant/award (A): 12,736 (derivative) @ $0EDGAR
2022-12-014BLACKBERRY Ltd (BB)Grant/award (A): 10,353 (derivative) @ $0EDGAR
2022-09-164PARDES BIOSCIENCES, INC. (PRDS)Grant/award (A): 75,000 (derivative) @ $0EDGAR
2022-09-014BLACKBERRY Ltd (BB)Grant/award (A): 8,653 (derivative) @ $0EDGAR
2022-06-214ARVINAS, INC. (ARVN)Grant/award (A): 10,192 (derivative) @ $0EDGAR
2022-06-154Kinnate Biopharma Inc. (KNTE)Grant/award (A): 20,250 (derivative) @ $0EDGAR
2022-06-014BLACKBERRY Ltd (BB)Grant/award (A): 8,859 (derivative) @ $0EDGAR
2022-04-284Theravance Biopharma, Inc. (TBPH)Grant/award (A): 9,852 @ $0 · Grant/award (A): 28,000 (derivative) @ $0EDGAR
2022-03-014BLACKBERRY Ltd (BB)Grant/award (A): 7,758 (derivative) @ $0EDGAR
2021-12-024BLACKBERRY Ltd (BB)Grant/award (A): 5,547 (derivative) @ $0EDGAR
2021-09-014BLACKBERRY Ltd (BB)Grant/award (A): 4,694 (derivative) @ $0EDGAR
2021-06-144Kinnate Biopharma Inc. (KNTE)Grant/award (A): 20,250 (derivative) @ $0EDGAR
2021-06-104ARVINAS, INC. (ARVN)Grant/award (A): 7,511 (derivative) @ $0EDGAR
2021-06-014BLACKBERRY Ltd (BB)Grant/award (A): 5,560 (derivative) @ $0EDGAR
2021-04-294Theravance Biopharma, Inc. (TBPH)Grant/award (A): 9,828 @ $0 · Grant/award (A): 6,000 (derivative) @ $0EDGAR
2021-03-024BLACKBERRY Ltd (BB)Grant/award (A): 5,245 (derivative) @ $0EDGAR
2020-12-024BLACKBERRY Ltd (BB)Grant/award (A): 8,823 (derivative) @ $0EDGAR
2020-09-024BLACKBERRY Ltd (BB)Grant/award (A): 9,927 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1589602 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs